Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAMCIS: Ferulic acid and Angelica archangelica extract in mild cognitive impairment
jRCT1091220187Completed
- Sponsor
- National Hospital Organization Hokuriku Medical Center
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Mild Cognitive Impairment (MCI) comparing Ferulic acid + Angelica archangelica extract with Placebo (2 arms). Primary endpoints: Mini-Mental State Examination (MMSE) and Wechsler Memory Scale-Revised (WMS-R). Started Jul 2014; status: completed.
02
Drugs
ferulic acid + angelica archangelica extract
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on jRCT1091220187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220187.